MA27.06 Therapeutic Silencing of Oncogenic KRAS With a Mutant-Specific Short Interfering RNA
Publication
, Conference
Pecot, C; Van Swearingen, A; Papke, B
Published in: Journal of Thoracic Oncology
October 2018
Duke Scholars
Published In
Journal of Thoracic Oncology
DOI
ISSN
1556-0864
Publication Date
October 2018
Volume
13
Issue
10
Start / End Page
S456 / S456
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Pecot, C., Van Swearingen, A., & Papke, B. (2018). MA27.06 Therapeutic Silencing of Oncogenic KRAS With a Mutant-Specific Short Interfering RNA. In Journal of Thoracic Oncology (Vol. 13, pp. S456–S456). Elsevier BV. https://doi.org/10.1016/j.jtho.2018.08.551
Pecot, C., A. Van Swearingen, and B. Papke. “MA27.06 Therapeutic Silencing of Oncogenic KRAS With a Mutant-Specific Short Interfering RNA.” In Journal of Thoracic Oncology, 13:S456–S456. Elsevier BV, 2018. https://doi.org/10.1016/j.jtho.2018.08.551.
Pecot C, Van Swearingen A, Papke B. MA27.06 Therapeutic Silencing of Oncogenic KRAS With a Mutant-Specific Short Interfering RNA. In: Journal of Thoracic Oncology. Elsevier BV; 2018. p. S456–S456.
Pecot, C., et al. “MA27.06 Therapeutic Silencing of Oncogenic KRAS With a Mutant-Specific Short Interfering RNA.” Journal of Thoracic Oncology, vol. 13, no. 10, Elsevier BV, 2018, pp. S456–S456. Crossref, doi:10.1016/j.jtho.2018.08.551.
Pecot C, Van Swearingen A, Papke B. MA27.06 Therapeutic Silencing of Oncogenic KRAS With a Mutant-Specific Short Interfering RNA. Journal of Thoracic Oncology. Elsevier BV; 2018. p. S456–S456.
Published In
Journal of Thoracic Oncology
DOI
ISSN
1556-0864
Publication Date
October 2018
Volume
13
Issue
10
Start / End Page
S456 / S456
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology